FDA is taking an initial step to advance treatment options for men’s health by encouraging sponsors of approved testosterone replacement therapy products to contact FDA for information if they are interested in pursuing a potential new indication for low libido in men with idiopathic hypogonadism.
Healthcare
FDA Takes Step Forward on Testosterone Therapy for Men
Source: FDA Press Releases — US Government, Public Domain